Category: Blog

About NETRF

The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.

Blog

NETRF Awards $3.5 Million in Grants

Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF)  today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12

Read More »
Blog

Celebrating the Next Chapter

After chemotherapy for pancreatic NET, Chef Jack Riebel embraces life with new optimism, doing what he enjoys most, and finding meaning by giving back.

Read More »
Blog

Spirituality and Cancer

Many people with neuroendocrine cancer look more deeply for meaning in their lives. They want to understand their purpose in life or why they got cancer.

Read More »
Blog

COMPETE Clinical Trial

A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,

Read More »
Blog

A Look at Lung NETs

Approximately 20% of all primary lung tumors are neuroendocrine (Hung 2019), including: Typical carcinoid (TC) Atypical carcinoid (AC) Small cell carcinoma (SCC) Large cell carcinoma

Read More »
Blog

Staying Safe from the Flu

Living with cancer increases your risk for complications from influenza (“flu”). If you have cancer now, have had cancer in the past, or live with

Read More »